Pharmacokinetics and Pharmacodynamics of Low Dose Mycophenolate Mofetil in HIV-Infected Patients Treated with Abacavir, Efavirenz and Nelfinavir

被引：0
作者：
Olga Millán
Mercé Brunet
Jaume Martorell
Felipe García
Elena Vidal
Isabel Rojo
Montserrat Plana
Teresa Gallart
Tomas Pumarola
Jose M. Miró
Jose M. Gatell
机构：
[1] Universitat de Barcelona,Servei Immunologia, Hospital Clínic, IDIBAPS
[2] Universitat de Barcelona,Servei Toxicologia, Hospital Clínic, IDIBAPS
[3] Universitat de Barcelona,Servei Infeccions, Hospital Clínic, IDIBAPS
[4] Universitate de Barcelona,Servei Microbiologia, Hospital Clínic, IDIBAPS
[5] Hospital Clinic de Barcelona,Servei Immunologia
来源：
Clinical Pharmacokinetics | 2005年 / 44卷
关键词：
Viral Load; Efavirenz; Mycophenolate Mofetil; Abacavir; Mycophenolic Acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：525 / 538
页数：13
相关论文
共 50 条
  • [41] Arzneimittelexantheme bei Therapie der HIV-Infektion mit Efavirenz und NevirapinRashes in HIV-infected patients undergoing therapy with nevirapine or efavirenz
    M. Hartmann
    J. Brust
    D. Schuster
    F. Mosthaf
    M. Procaccianti
    J. A. Rump
    H. Klinker
    D. Petzoldt
    Der Hautarzt, 2005, 56 (9): : 847 - 853
  • [42] Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers
    Zhao, Wei
    Cella, Massimo
    Della Pasqua, Oscar
    Burger, David
    Jacqz-Aigrain, Evelyne
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (04) : 641 - 650
  • [43] Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz
    Calza, Leonardo
    Magistrelli, Eleonora
    Danese, Ilaria
    Colangeli, Vincenzo
    Borderi, Marco
    Bon, Isabella
    Re, Maria Carla
    Mancini, Rita
    Conti, Matteo
    Motta, Roberto
    Viale, Pierluigi
    CURRENT HIV RESEARCH, 2016, 14 (01) : 61 - 70
  • [44] Minimum effective plasma concentration of efavirenz in treatment-naive Chinese HIV-infected patients
    Sun, J.
    Chen, J.
    Yao, Y.
    Zhang, R.
    Zheng, Y.
    Liu, L.
    Zhang, L.
    Shen, Y.
    Lu, H.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (12) : 810 - 813
  • [45] Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients
    Ma, Qing
    Vaida, Florin
    Wong, Jenna
    Sanders, Chelsea A.
    Kao, Yu-ting
    Croteau, David
    Clifford, David B.
    Collier, Ann C.
    Gelman, Benjamin B.
    Marra, Christina M.
    McArthur, Justin C.
    Morgello, Susan
    Simpson, David M.
    Heaton, Robert K.
    Grant, Igor
    Letendre, Scott L.
    JOURNAL OF NEUROVIROLOGY, 2016, 22 (02) : 170 - 178
  • [46] Efavirenz plasma concentrations in HIV-infected patients -: Inter- and intraindividual variability and clinical effects
    Stähle, L
    Moberg, L
    Svensson, JO
    Sönnerborg, A
    THERAPEUTIC DRUG MONITORING, 2004, 26 (03) : 267 - 270
  • [47] Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients
    Qing Ma
    Florin Vaida
    Jenna Wong
    Chelsea A. Sanders
    Yu-ting Kao
    David Croteau
    David B. Clifford
    Ann C. Collier
    Benjamin B. Gelman
    Christina M. Marra
    Justin C. McArthur
    Susan Morgello
    David M. Simpson
    Robert K. Heaton
    Igor Grant
    Scott L. Letendre
    Journal of NeuroVirology, 2016, 22 : 170 - 178
  • [48] Association of Human Leukocyte Antigen Alleles and Hypersensitivity of Efavirenz/Nevirapine in HIV-Infected Chinese Patients
    Zhou, Xiao-Yan
    Li, Chong-Xi
    Zhang, Jian-Bo
    Tan, Jun-Ting
    Xi-Yang, Xi
    Albarmaqi, Rowida A.
    Li, Yu-Ye
    Kuang, Yi-Qun
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2022, 38 (12) : 884 - 889
  • [49] Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia
    Thamrongwonglert, Pornpimol
    Chetchotisakd, Ploenchan
    Anunnatsiri, Siriluck
    Mootsikapun, Piroon
    HIV CLINICAL TRIALS, 2016, 17 (01): : 12 - 16
  • [50] Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results
    Princy Kumar
    Edwin DeJesus
    Gregory Huhn
    Louis Sloan
    Catherine Butkus Small
    Howard Edelstein
    Franco Felizarta
    Ritche Hao
    Lisa Ross
    Britt Stancil
    Keith Pappa
    Belinda Ha
    BMC Infectious Diseases, 13
12345